US Patent Issued to UNIVERSIDAD DE CHILE on June 2 for "Virus AAV/IGF2, genetic treatment method and use thereof in protein misfolding-related diseases, such as Huntington's disease" (Chilean Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,872, issued on June 2, was assigned to UNIVERSIDAD DE CHILE (Santiago, Chile).

"Virus AAV/IGF2, genetic treatment method and use thereof in protein misfolding-related diseases, such as Huntington's disease" was invented by Claudio Andres Hetz Flores (Independencia, Chile) and Paula Garcia Huerta (Independencia, Chile).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the expression of two molecules in viral vectors AAV/IGF2-HA and AAV/IGF2, the associated method and use thereof in the amelioration of protein misfolding-related diseases, such as Huntington's disease, as presented in the in vivo models in FIGS. 11/19."

The patent ...